Tag: Macular Degeneration

Distinct serum and genetic risks, associated systemic diseases seen with soft drusen, subretinal drusenoid deposits

Model compares costs for ranibizumab port delivery system versus conventional intravitreal antivascular endothelial growth factor injections

No increased risk for lung cancer, reduced risk for progression to late AMD seen with lutein/zeaxanthin as replacement for beta-carotene

Odds of prior migraine increased for those with neovascular AMD versus propensity score-matched controls

Faricimab noninferior to aflibercept for visual acuity gains in neovascular age-related macular degeneration, diabetic macular edema

Treated patients who required less frequent anti-VEGF injections had increased apolipoprotein B100

Findings based on mendelian randomization for genetically predicted smoking initiation, alcohol intake

Biosimilar to Lucentis approved to treat neovascular age-related macular degeneration, macular edema, myopic choroidal neovascularization

Exposure to different pollutants including PM_2.5, NO₂, NO_x linked to differences in retinal layer thickness